Bern-Thomas Nyang'wa

8PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsEpidemiological methodsGene and molecular therapyMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 10, 2026
Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatment.

|May 13, 2026
Quality of life outcomes and patient-reported experiences in a randomised controlled trial for rifampicin-resistant TB (PRACTECAL-PRO): a mixed-methods study.

|Mar 31, 2026
Population pharmacokinetics and target attainment of pretomanid in rifampicin-resistant tuberculosis patients.

Bern-Thomas Nyang'wa, Ilaria Motta, Ronelle Moodliar

|Apr 23, 2025
Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens.

Dzintars Gotham, Manuel Martin, Melissa J Barber

|Mar 24, 2023
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis.

Sedona Sweeney, Catherine Berry, Emil Kazounis

|Sep 07, 2021
Population pharmacokinetics and pharmacodynamics of investigational regimens' drugs in the TB-PRACTECAL clinical trial (the PRACTECAL-PKPD study): a prospective nested study protocol in a randomised controlled trial.

Bern-Thomas Nyang'wa, Frank Kloprogge, David A J Moore

Pageof 2

Frequent Collaborators

3 joint publications

Frank Kloprogge

2 joint publications

Beverley Stringer

2 joint publications

Catherine Berry

1 joint publications

K Lowton